PATENT CLAIM ANALYSIS

Application Number: 16245397
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-06
Patent Classification: ["424", "078180"]

Abstract:
The invention provides methods and polymer compositions for treating retinal detachment and other ocular disorders, where the methods employ polymer compositions that can form a hydrogel in the eye of a subject. The hydrogel is formed by reaction of (i) a nucleo-functional polymer that is a biocompatible polymer containing a plurality of thio-functional groups —R 1 —SH wherein R 1  is an ester-containing linker, such as a thiolated poly(vinyl alcohol) polymer and (ii) an electro-functional polymer that is a biocompatible polymer containing at least one thiol-reactive group, such as a poly(ethylene glycol) polymer containing alpha-beta unsaturated ester groups.

Claim (Index 140):
The method of  claim 128 , wherein the mole ratio of (i) thio-functional groups \u2014R 1 \u2014SH to (ii) the at least one thiol-reactive group is in the range of 10:1 to 1:10, 5:1 to 1:1, or 2:1 to 1:1.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 99.0
- Lexical Diversity: 1.68657
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14372258', '11653433', '15882244', '12871923', '15213147']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6958272513703121
- 35 USC 102 Novelty (BERT): 0.5100683100900202
- Combined Prediction Score: 0.6772513572422829
- Mean Citation Score: 192.20601
- Max Citation Score: 195.54688
- Similarity Product: 116.94811666458128

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test